Martijn Kleijwegt founded LSP in 1998 and is currently a Managing Partner and co-owner of the firm. He joined the Arvelle Board in 2019. Martijn’s prime focus and responsibility within LSP is to invest in unlisted securities and the general management of the firm. Prior to establishing LSP, Martijn ran another investment firm where he was responsible for investments in the healthcare sector. As one of Europe’s most experienced healthcare investors, Martijn brings over 30 years of hands-on finance and investment experience to the LSP team. He has also been appointed a Director of a large number of companies, all of which he helped to grow and flourish. Among others, Martijn currently serves as a Director of Kiadis Pharma, Orphazyme AS, OxThera AB, Pharvaris BV and Eloxx Pharmaceuticals. Martijn lives in Amsterdam and has three children.